BSECompany Update1d ago · 17 Nov 2026, 05:13 pm
Schedule of Investor Meet Intimation
Gland Pharma Ltd · 543245
✦ AI SummaryMgmt Change
Gland Pharma Ltd has announced the schedule of analyst/institutional investor meetings, including a one-on-one meeting with ADIA on November 20, 2026. The schedule is subject to change due to exigencies.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation